Article
Chromophobe TCCs have better prognosis than clear-cell, papillary tumors
A large, international, multicenter study has shattered one common assumptionabout renal cell carcinoma. The overall prognosis for chromophobe carcinomasis better than for clear-cell or papillary tumors, rather than the opposite.However, all three tumor types have equivalent survival when adjusted forstage and grade.
Related Videos
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Alternative treatments and patient communication for genitourinary syndrome of menopause
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Treatment or Lack of Treatment of Small Renal Masses
The current treatment landscape of mHSPC
Strengths and Weaknesses of Imaging Modalities in ccRCC
BPH: Strategies for Guiding Patients From Medication to Intervention
Related Content
